Metraipolis › archive › dc_78082f79b4cb

Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies — Europe PMC PMID:42652115

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42652115
DOI
10.3390/biomedicines14081732
License (as archived)
solo-consultazione
Archived
2026-10-17T06:59:42.172Z
SHA-256 of the archived text
e811c1c2c4ff0dbd6814a1decf877b496fa52f455a735040bcc4b880741c4258
Stable URL of this page
https://metraipolis.com/documento/dc_78082f79b4cb

How to cite

Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies — Europe PMC PMID:42652115 — Europe PMC (en), https://europepmc.org/article/MED/42652115 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_78082f79b4cb (Metraipolis archive dc_78082f79b4cb, sha256 e811c1c2c4ff0dbd6814a1decf877b496fa52f455a735040bcc4b880741c4258)
BibTeX
@misc{dc78082f79b4cb,
  title = {Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies — Europe PMC PMID:42652115},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42652115},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_78082f79b4cb; sha256 e811c1c2c4ff0dbd6814a1decf877b496fa52f455a735040bcc4b880741c4258},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652115. Agents can read the archived copy with the MCP tool read_document.